Advanced search
Publication Cover
Expert Review of Medical Devices Volume 10, 2013 - Issue 2
Submit an article Journal homepage
110
Views
7
CrossRef citations to date
0
Altmetric
Review

Percutaneous transcatheter aortic valve implantation: present and future perspective

Diego Fernández Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain; Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain
,
Joaquim Cevallos Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain; Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain
,
Salvatore Brugaletta Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain; Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain. [email protected]
,
Victoria Martín-Yuste Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain; Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain
,
Xavier Freixa Division of Cardiology, Montreal Heart Institute, University of Montreal, Interventional Cardiology Program, Montreal, QC, Canada; Division of Cardiology, Montreal Heart Institute, University of Montreal, Interventional Cardiology Program, Montreal, QC, Canada
,
Ruth Andrea Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain; Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain
,
Carlos Falces Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain; Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain
,
Ander Regueiro-Cueva Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain; Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain
,
Mónica Masotti Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain; Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain
&
Manel Sabaté Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain; Thorax Institute, Hospital Clínic, University of Barcelona, IDIBAPS, C/ Villarroel 170, 08036 Barcelona, Spain
 show all
Pages 185-199 | Published online: 09 Jan 2014

References

  • Holmes DR Jr, Mack MJ, Kaul S et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J. Am. Coll. Cardiol. 59(13), 1200–1254 (2012).
  • Bonow RO, Carabello BA, Kanu C et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114(5), e84–231 (2006).
  • Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24(13), 1231–1243 (2003).
  • Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106(24), 3006–3008 (2002).
  • Kim W-J. Learning from the cases of TAVI. Presented at: IPS Congress, London, UK, 20–22 September 2010.
  • Rodés-Cabau J. Transcatheter aortic valve implantation: current and future approaches. Nat. Rev. Cardiol. 9(1), 15–29 (2012).
  • Blais C, Dumesnil JG, Baillot R, Simard S, Doyle D, Pibarot P. Impact of valve prosthesis-patient mismatch on short-term mortality after aortic valve replacement. Circulation 108(8), 983–988 (2003).
  • Giannini C, Petronio AS, Talini E et al. Early and late improvement of global and regional left ventricular function after transcatheter aortic valve implantation in patients with severe aortic stenosis: an echocardiographic study. Am. J. Cardiovasc. Dis. 1(3), 264–273 (2011).
  • Rodés-Cabau J, DeLarochellière R, Dumont E. First-in-man transcatheter aortic valve implantation of a 20-mm Edwards SAPIEN XT valve: one step forward for the treatment of patients with severe aortic stenosis and small aortic annulus. Catheter. Cardiovasc. Interv. 79(5), 789–793 (2012).
  • Pasic M, Dreysse S, Drews T et al. Improved technique of transapical aortic valve implantation: ‘the Berlin addition’. Ann. Thorac. Surg. 89(6), 2058–2060 (2010).
  • Mok M, Dumont E, Doyle D, Rodés-Cabau J. Transcatheter aortic valve implantation using the slow balloon inflation technique: making balloon-expandable valves partially repositionable. J. Card. Surg. 27(5), 546–548 (2012).
  • Chorianopoulos E, Krumsdorf U, Pleger ST, Katus HA, Bekeredjian R. Improved procedural results after CoreValve implantation with the new AccuTrak delivery system. J. Interv. Cardiol. 25(2), 174–179 (2012).
  • Tchetche D, Modine T, Farah B et al. Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system. EuroIntervention 8(5), 556–562 (2012).
  • Wood DA, Tops LF, Mayo JR et al. Role of multislice computed tomography in transcatheter aortic valve replacement. Am. J. Cardiol. 103(9), 1295–1301 (2009).
  • Tzikas A, Schultz C, Van Mieghem NM, de Jaegere PP, Serruys PW. Optimal projection estimation for transcatheter aortic valve implantation based on contrast-aortography: validation of a Prototype Software. Catheter. Cardiovasc. Interv. 76(4), 602–607 (2010).
  • Dvir D, Kornowski R. Percutaneous aortic valve implantation using novel imaging guidance. Catheter. Cardiovasc. Interv. 76(3), 450–454 (2010).
  • Moat NE, Ludman P, de Belder MA et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J. Am. Coll. Cardiol. 58(20), 2130–2138 (2011).
  • Gilard M, Eltchaninoff H, Iung B et al.; FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N. Engl. J. Med. 366(18), 1705–1715 (2012).
  • Ussia GP, Barbanti M, Petronio AS et al.; CoreValve Italian Registry Investigators. Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis. Eur. Heart J. 33(8), 969–976 (2012).
  • Bosmans JM, Kefer J, De Bruyne B et al.; Belgian TAVI Registry Participants. Procedural, 30-day and one year outcome following CoreValve or Edwards transcatheter aortic valve implantation: results of the Belgian national registry. Interact. Cardiovasc. Thorac. Surg. 12(5), 762–767 (2011).
  • Buellesfeld L, Gerckens U, Grube E. Percutaneous implantation of the first repositionable aortic valve prosthesis in a patient with severe aortic stenosis. Catheter. Cardiovasc. Interv. 71(5), 579–584 (2008).
  • Falk V, Walther T, Schwammenthal E et al. Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur. Heart J. 32(7), 878–887 (2011).
  • Kempfert J, Rastan AJ, Beyersdorf F et al. Trans-apical aortic valve implantation using a new self-expandable bioprosthesis: initial outcomes. Eur. J. Cardiothorac. Surg. 40(5), 1114–1119 (2011).
  • Kempfert J, Rastan AJ, Mohr FW, Walther T. A new self-expanding transcatheter aortic valve for transapical implantation – first in man implantation of the JenaValve™. Eur. J. Cardiothorac. Surg. 40(3), 761–763 (2011).
  • Treede H, Mohr FW, Baldus S et al. Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study. Eur. J. Cardiothorac. Surg. 41(6), e131–e138 (2012).
  • Willson AB, Rodès-Cabau J, Wood DA et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J. Am. Coll. Cardiol. 60(7), 581–586 (2012).
  • Schofer J, Schlüter M, Treede H et al. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study. Circ. Cardiovasc. Interv. 1(2), 126–133 (2008).
  • Treede H, Tübler T, Reichenspurner H et al. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the direct flow medical aortic valve. J. Thorac. Cardiovasc. Surg. 140(4), 897–903 (2010).
  • Gaia DF, Palma JH, Ferreira CB et al. Transapical aortic valve implantation: results of a Brazilian prosthesis. Rev. Bras. Cir. Cardiovasc. 25(3), 293–302 (2010).
  • Gaia DF, Palma JH, Ferreira CB et al. Transcatheter aortic valve implantation: results of the current development and implantation of a new Brazilian prosthesis. Rev. Bras. Cir. Cardiovasc. 26(3), 338–347 (2011).
  • Levi DS, Kusnezov N, Carman GP. Smart materials applications for pediatric cardiovascular devices. Pediatr. Res. 63(5), 552–558 (2008).
  • Leon MB, Smith CR, Mack M et al.; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363(17), 1597–1607 (2010).
  • Makkar RR, Fontana GP, Jilaihawi H et al.; PARTNER Trial Investigators. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N. Engl. J. Med. 366(18), 1696–1704 (2012).
  • Smith CR, Leon MB, Mack MJ et al.; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364(23), 2187–2198 (2011).
  • Kodali SK, Williams MR, Smith CR et al.; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J. Med. 366(18), 1686–1695 (2012).
  • Hlatky MA, Simons CT. Cost–effectiveness of transcatheter aortic valve replacement. Circulation 125(9), 1076–1077 (2012).
  • Gurvitch R, Tay EL, Wijesinghe N et al. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter. Cardiovasc. Interv. 78(7), 977–984 (2011).
  • Leon MB, Piazza N, Nikolsky E et al. Standardized end point definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur. Heart J. 32(2), 205–217 (2011).
  • Wendler O. 30 Day outcome from the SOURCE XT TAVI post-approval Study. Presented at: EuroPCR. Paris, France, 15–18 May (2012).
  • Zahn R, Gerckens U, Grube E et al.; German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur. Heart J. 32(2), 198–204 (2011).
  • Lefèvre T, Kappetein AP, Wolner E et al.; PARTNER EU Investigator Group. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur. Heart J. 32(2), 148–157 (2011).
  • Eltchaninoff H, Prat A, Gilard M et al.; FRANCE Registry Investigators. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur. Heart J. 32(2), 191–197 (2011).
  • Thomas M, Schymik G, Walther T et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 124(4), 425–433 (2011).
  • Kahlert P, Knipp SC, Schlamann M et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121(7), 870–878 (2010).
  • Ghanem A, Müller A, Nähle CP et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J. Am. Coll. Cardiol. 55(14), 1427–1432 (2010).
  • Rodés-Cabau J, Dumont E, Boone RH et al. Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J. Am. Coll. Cardiol. 57(1), 18–28 (2011).
  • Nietlispach F, Wijesinghe N, Gurvitch R et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc. Interv. 3(11), 1133–1138 (2010).
  • Naber CK, Ghanem A, Abizaid AA et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 8(1), 43–50 (2012).
  • Onsea K, Agostoni P, Samim M et al. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions. EuroIntervention 8(1), 51–56 (2012).
  • Nuis RJ, Van Mieghem NM, Tzikas A et al. Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter. Cardiovasc. Interv. 77(6), 881–889 (2011).
  • Sinning JM, Ghanem A, Steinhäuser H et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC. Cardiovasc. Interv. 3(11), 1141–1149 (2010).
  • Elhmidi Y, Bleiziffer S, Piazza N et al. Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am. Heart J. 161(4), 735–739 (2011).
  • Houthuizen P, Van Garsse LA, Poels TT et al. Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death. Circulation 126(6), 720–728 (2012).
  • Fraccaro C, Buja G, Tarantini G et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am. J. Cardiol. 107(5), 747–754 (2011).
  • Khawaja MZ, Rajani R, Cook A et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 123(9), 951–960 (2011).
  • Fiorina C, Curello S, Maffeo D, Lorusso R, Chizzola G, Ettori F. Management of acute left main obstruction after transcatheter aortic valve replacement: the ‘tunnel technique’. Cardiovasc. Revasc. Med. 13(2), 142.e5–142.e9 (2012).
  • Rodés-Cabau J, Dumont E, Doyle D. ‘Valve-in-valve’ for the treatment of paravalvular leaks following transcatheter aortic valve implantation. Catheter. Cardiovasc. Interv. 74(7), 1116–1119 (2009).
  • Zegdi R, Ciobotaru V, Noghin M et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J. Am. Coll. Cardiol. 51(5), 579–584 (2008).
  • Schultz CJ, Weustink A, Piazza N et al. Geometry and degree of apposition of the CoreValve ReValving system with multislice computed tomography after implantation in patients with aortic stenosis. J. Am. Coll. Cardiol. 54(10), 911–918 (2009).
  • Hammerstingl C, Werner N, Nickenig G. Symptomatic paravalvular leakage after mechanical aortic valve replacement in a critically ill patient: why not just ‘plug’ the hole? Eur. J. Echocardiogr. 10(4), 576–578 (2009).
  • Shapira Y, Hirsch R, Kornowski R et al. Percutaneous closure of perivalvular leaks with Amplatzer occluders: feasibility, safety, and shortterm results. J. Heart Valve Dis. 16(3), 305–313 (2007).
  • Sarkar K, Sardella G, Romeo F et al. Transcatheter aortic valve implantation for severe regurgitation in native and degenerated bioprosthetic aortic valves. Catheter. Cardiovasc. Interv. doi:10.1002/ccd.24479 (2012) (Epub ahead of print).
  • Greif M, Lange P, Mair H et al. Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access. Clin. Res. Cardiol. 101(12), 993–1001 (2012).
  • Pasic M, Unbehaun A, Dreysse S et al. Transapical aortic valve implantation after previous aortic valve replacement: clinical proof of the ‘valve-in-valve’ concept. J. Thorac. Cardiovasc. Surg. 142(2), 270–277 (2011).
  • Zahn R, Schiele R, Kilkowski C et al. Correction of aortic regurgitation after transcatheter aortic valve implantation of the Medtronic CoreValve™ prosthesis due to a too-low implantation, using transcatheter repositioning. J. Heart Valve Dis. 20(1), 64–69 (2011).
  • Dewey TM, Brown DL, Herbert MA et al. Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann. Thorac. Surg. 89(3), 758–767; discussion 767 (2010).
  • Abdel-Wahab M, Mostafa AE, Geist V et al. Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with preprocedural percutaneous coronary intervention. Am. J. Cardiol. 109(4), 581–586 (2012).
  • Clavel MA, Webb JG, Rodés-Cabau J et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 122(19), 1928–1936 (2010).
  • Muñoz-García AJ, Jiménez-Navarro MF, Rodríguez-Bailón I et al. Impact of transcatheter aortic valve implantation with the CoreValve prosthesis in patients with severe aortic stenosis and left ventricular dysfunction. Int. J. Cardiol. 157(1), 124–125 (2012).
  • D’Ancona G, Pasic M, Buz S et al. Transapical transcatheter aortic valve replacement in patients with cardiogenic shock. Interact. Cardiovasc. Thorac. Surg. 14(4), 426–430 (2012).
  • Doebler K, Boukamp K, Mayer ED. Indication and structures and management of transcatheter aortic valve implantation: a review of the literature. Thorac. Cardiovasc. Surg. 60(5), 309–318 (2012).
  • Gurvitch R, Wood DA, Tay EL et al. Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3 years in a large patient cohort. Circulation 122(13), 1319–1327 (2010).
  • Ussia GP, Scarabelli M, Mulè M et al. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am. J. Cardiol. 108(12), 1772–1776 (2011).
  • Walther T, Simon P, Dewey T et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 116(11 Suppl.), I240–I245 (2007).
  • Wenaweser P, Pilgrim T, Roth N et al. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am. Heart J. 161(6), 1114–1124 (2011).
  • Motloch LJ, Rottlaender D, Reda S et al. Local versus general anesthesia for transfemoral aortic valve implantation. Clin. Res. Cardiol. 101(1), 45–53 (2012).
  • Sharp AS, Michev I, Maisano F et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter. Cardiovasc. Interv. 75(5), 784–793 (2010).
  • Vergnat M, Finet G, Rioufol G, Obadia JF. Percutaneous femoral artery access with Prostar device for innovative mitral and aortic interventions. Eur. J. Cardiothorac. Surg. 39(4), 600–602 (2011).
  • Hayashida K, Lefèvre T, Chevalier B et al. True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications. JACC Cardiovasc. Interv. 5(2), 207–214 (2012).
  • Walther T, Kempfert J, Mohr FW. Transcatheter aortic valve implantation: surgical perspectives. Arch. Cardiovasc. Dis. 105(3), 174–180 (2012).
  • Latsios G, Gerckens U, Grube E. Transaortic transcatheter aortic valve implantation: a novel approach for the truly ‘no-access option’ patients. Catheter. Cardiovasc. Interv. 75(7), 1129–1136 (2010).
  • Bapat V, Khawaja MZ, Attia R et al. Transaortic Transcatheter Aortic valve implantation using Edwards Sapien valve: a novel approach. Catheter. Cardiovasc. Interv. 79(5), 733–740 (2012).
  • Nombela-Franco L, Rodés-Cabau J, Doyle D et al. Transaortic transcatheter aortic valve implantation: potential issues associated with the use of the ASCENDRA transapical delivery system. J. Card. Surg. 27(4), 438–440 (2012).
  • Witkowski A, Dabrowski M, Chmielak Z et al. Transcatheter aortic valve implantation using transfemoral/transsubclavian or transapical approach: 30-day follow-up of the initial 30 patients. Kardiol. Pol. 69(2), 105–114 (2011).
  • Cioni M, Taramasso M, Giacomini A et al. Transaxillary approach: short- and mid-term results in a single-center experience. Innovations (Phila.) 6(6), 361–365 (2011).
  • Schäfer U, Ho Y, Frerker C et al. Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: ‘the Hamburg Sankt Georg approach’. JACC Cardiovasc. Interv. 5(5), 477–486 (2012).
  • Chu MW, Falk V, Mohr FW, Walther T. Percutaneous endoscopic transapical aortic valve implantation: three experimental transcatheter models. Interact. Cardiovasc. Thorac. Surg. 13(3), 251–256 (2011).
  • Routledge HC, Lefevre T, Morice MC, De Marco F, Salmi L, Cormier B. Percutaneous aortic valve replacement: new hope for inoperable and high-risk patients. J. Invasive Cardiol. 19(11), 478–483 (2007).
  • Thomas M, Schymik G, Walther T et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122(1), 62–69 (2010).
  • Rodés-Cabau J, Webb JG, Cheung A et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J. Am. Coll. Cardiol. 55(11), 1080–1090 (2010).
  • Gurvitch R, Toggweiler S, Willson AB et al. Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve Academic Research Consortium (VARC) guidelines. EuroIntervention 7(1), 41–48 (2011).
  • Buchanan GL, Chieffo A, Montorfano M et al. The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards SAPIEN™ and Medtronic CoreValve ReValving System® devices: the Milan registry. EuroIntervention 7(5), 556–563 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.